What does CJC-1295 stand for?

This site's CJC-1295 profile does not treat the letters as an amino-acid abbreviation. CJC-1295 is a development code for a growth hormone releasing hormone analogue. DAC, listed as an alias, stands for Drug Affinity Complex, the albumin-binding modification that stretches half-life. Two 2006 randomized trials in healthy adults estimated that half-life at 5.8 to 8.1 days and found a single injection raised mean growth hormone two- to tenfold for six days or more. Neither version is FDA approved. The letters are a code, not a brand ranking and not a dose.

Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use.

Part of further names and published absences. Leftover harvested questions after the first two absence sets: more brand versus molecule names, side effects the citations did not count, compounding formulas this catalogue does not hold, national FDA and Australia fields, trial windows rather than an onset clock, named combinations with no interaction table, and oral routes that have not been studied.